GSIAS
NVO

Garden State Investment Advisory Services’s Novo Nordisk NVO Stock Holding History

Garden State Investment Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,059
Closed -$487K – 337
2025
Q2 		$487K Buy
7,059
+3,167
+81% +$215K 0.12% 151
2025
Q1 		$274K Buy
3,892
+273
+8% +$22.5K 0.09% 193
2024
Q4 		$312K Buy
3,619
+1,476
+69% +$160K 0.09% 176
2024
Q3 		$255K Sell
2,143
-130
-6% -$17.3K 0.08% 189
2024
Q2 		$325K Sell
2,273
-179
-7% -$23.7K 0.11% 158
2024
Q1 		$314K Buy
2,452
+383
+19% +$45.6K 0.11% 166
2023
Q4 		$214K Buy
+2,069
New +$205K 0.09% 190

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Garden State Investment Advisory Services's NVO Position: Q3 2025 in Review

Garden State Investment Advisory Services sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 7,059 shares — an estimated $487K sold.

Garden State Investment Advisory Services first reported a position in NVO in Q4 2023 and held it in 7 quarters. The position peaked at $487K in Q2 2025. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Garden State Investment Advisory Services reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Garden State Investment Advisory Services sold 7,059 Novo Nordisk shares in Q3 2025, an estimated $487K.
  • Garden State Investment Advisory Services first reported a position in Novo Nordisk in Q4 2023 and held it in 7 quarters.
  • Garden State Investment Advisory Services's Novo Nordisk position peaked at $487K in Q2 2025.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Garden State Investment Advisory Services's 13F filing for Q3 2025, filed 14 Nov 2025.